|Blogs||Articles||Organizations||Biography||Jack's Book||Contact Information||Links|
Navigation: SOS Sisson > Life Ethics Blog
Jack Sisson's Life Ethics Blog
We must find new ways through many ethical issues, especially regarding bioethics, medical ethics, and criminal justice. Jack Sisson's 'Life Ethics' blog focuses on numerous areas of concern, including the philosophical and ethical dilemmas surrounding stem-cell research, abortion, medical research, and health care.
Thursday, November 22, 2012
We wish all our readers a safe, healthy and peaceful Thanksgiving.
We have much to be thankful for,
although we might not always remember that.
It's nice to have a day to think about what's really important
and give thanks for our many blessings.
Sunday, November 18, 2012
Advair: How Safe Is This Drug?
This article was of particular interest to me because I've inhaled Advair twice a day for several years now. Since I have only mild asthma, I plan to discuss alternatives during my next visit with my doctor.
From MedPage Today:
The 2001 product launch of the asthma drug Advair (fluticasone/salmeterol) was a lavish, Las Vegas affair.
Using images of a slot machine to illustrate their message, top GlaxoSmithKline executives took the stage in front of thousands of assembled sales reps. "There are people in this room who are going to make an ungodly sum of money selling Advair," one executive told the group.
He was right.
The Serious Business of Asthma
Millions of people with asthma, including many children, have gone on the drug and, according to data from IMS, Advair sales have exceeded $4 billion every year since 2007.
Yet even as profits mounted evidence began to emerge from independent medical studies and court records suggesting that the drug can be dangerous, especially to children and that overuse of the drug exacerbated the danger.
Asthma is not a benign condition.
According to the U.S. Centers for Disease Control and Prevention, asthma deaths in the U.S. have been declining since the late 1990s. In 2009, there were 3,388 asthma deaths.
The problem appears to be the long-acting beta-agonist salmeterol that is one component of Advair.
Asthma, which affects an estimated 25 million Americans, is caused by inflammation and swelling of the airways in the lungs as well as constriction of those airways. Long-acting beta-agonists, or LABAs as they are frequently referenced, which treat airway constriction, which provides symptom relief, while corticosteroids treat inflammation.
But long-acting beta-agonists have been linked to 1,900 asthma deaths from 2004 through 2011, according to an estimate provided by AdverseEvents Inc., a private firm that analyzes drug side effect data reported to the U.S. Food and Drug Administration. Because of the voluntary nature of those adverse event reports, it is likely that estimate is low.
In 2008 a different analysis by a researcher with the U.S. Food and Drug Administration estimated the drugs contributed to 14,000 asthma deaths from 1994 through 2007. Advair, approved in 2000, is by far the biggest seller.
The story of how a potentially dangerous drug became commonly prescribed comes from a Journal Sentinel/MedPage Today review of transcripts of FDA hearings, financial disclosures, medical journal articles, treatment guidelines and a U.S. Department of Justice complaint against GlaxoSmithKline.
Birth of a Blockbuster
Advair was considered a breakthrough in convenience because it combined the GlaxoSmithKline two effective agents, salmeterol to treat airway constriction and the corticosteroid fluticasone to treat inflammation.
Advair and similar drugs are considered appropriate treatment for severe, treatment-refractory asthma that is not controlled by corticosteroid treatment alone. But a 2010 study by Medco Health Solutions found nearly two-thirds of mild asthma patients were taking the combination drug -- often without trying a steroid first.
One theory for why Advair and similar drugs carry increased risk of deadly attacks is that the long-acting beta-agonists may mask worsening inflammation in the lungs. As a result, the patient "feels better" even as the disease worsens, thus setting the stage for a catastrophic asthma exacerbation. Assessing Risk, Risking Safety
In 2010, when the FDA approved more large-scale safety trials of the drugs, some of its own researchers called doing so unethical because it could put tens of thousands of patients at risk, according to a transcript.
Such trials would be especially dangerous for children, agency physician Andrew Mosholder, MD, warned, noting children "can't give consent themselves and one could argue the ethical burden is greater to protect."
The trials, which are not expected to yield results until 2017, will involve 46,800 adults and adolescents aged 12 and older. A separate trial involving 6,200 four- to 11-year-olds also is being conducted.
At a 2008 FDA advisory panel reviewing the use of the drugs, agency physician David Graham, MD, questioned whether it was worth putting an entire population on the drugs just to find that occasional patient who gets better control of their asthma, according to a transcript of the meeting.
"We have no way of identifying who's going to have that miraculous response to Advair," he said, "just as we have no way or predicting who's going to end up in the cemetery because of Advair."
Graham has a long-standing reputation as a FDA whistleblower, who has testified at Congressional hearings investigating the marketing of Merck's arthritis pain drug Vioxx, withdrawn after it was linked to heart attacks, and the diabetes drug Avandia, a GlaxoSmithKline drug, which was linked to increased risk of heart attacks.
FDA spokeswoman Morgan Liscinsky noted in an emailed statement that in 2010, the agency instituted new safety requirements for the drugs, including that they only should be used for the shortest duration necessary to achieve control of symptoms and then discontinued if possible.
In addition, the agency said long-acting beta-agonists should only be used with a steroid. The agency also issued warnings in 2006 about the increased risk of deadly attacks.
Liscinsky said the FDA believes the benefits of the drugs outweigh the risks when they are used properly.
Sunday, November 04, 2012
Effects of supplements on medicines 'dangerous'
From the Nursing Times:
Herbal remedies such as echinacea and St John’s Wort “could make medication dangerous”, the Daily Mail has warned.Read the entire article here.
Saturday, November 03, 2012
Early dementia diagnosis poses issues for patients, caregivers
From The Los Angeles Times:
Getting an early diagnosis of dementia could lead to finding ways to cope — and it could mean feeling bereft at what the future holds. So do you want to know?
The researchers, from several British universities, reviewed 102 studies from 14 countries to consider the ramifications on patients and caregivers of a dementia diagnosis. They reported their findings in the journal Public Library of Science-Medicine.
Their findings, they said, suggest that research is needed into evaluating interventions after diagnosis. By 2050, more than 115 million people worldwide will be diagnosed with dementia, they noted.
The studies involved 1,145 people with dementia and 1,950 informal caregivers. They lived in 14 countries, though primarily in the United Kingdom and North America. While most of the people were white, the researchers said several studies focused on nonwhite people.
The researchers found three broad themes: barriers to early diagnosis; the impact of the diagnosis; and living with dementia.
Among the barriers to diagnosis was – not surprisingly – the stigma attached to dementia. The researchers said a trigger event, such as a hospitalization, often preceded diagnosis. Relatives often recognized a problem before the patient, the researchers said.
Post-diagnosis, patients had similar problems adjusting to be being a person with dementia – leading to anger, uncertainty and frustration, the researchers said. While many people struggled to preserve aspects of their former selves and relationships, the researchers said most patients and caregivers eventually reached a state of acceptance. Sometimes diagnosis came as a relief, validating suspicions.
Caregivers may be torn between protecting the loved one and promoting his or her independence; often as well the patient and family struggle to maintain the patient’s previous identity while assimilating the new one. Some people seek all the information possible, while others rejected it – feeling there was no point in knowing. “Better knowledge-sharing at the point of diagnosis was not always the solution,” the researchers said.
The researchers said they found “a clear need for great support after diagnosis, including advice, social and psychological support, access to community care and respite.”
Friday, November 02, 2012
HMO Problems - Let's Start Here
If you or anyone you know have had HMO problems, then you can understand how this type of medical insurance tends to send people screaming in the other direction. It may or may not save you money, depending on the problems you come across, and the illness you're trying to get treated. Some of the problems are common and you can get around them, others can be more difficult and cost you more money and time.
For example. Someone I know had a broken jaw. She went to a doctor listed with HMO and had her jaw set and wired together. It was like this for four months. Anyone who's had their jaw wired, knows this is no picnic.
After a month, she started having problems with her jaw. It hurt all the time and from looking at her, you could see the jaw was dropping and not aligned properly. She went back to the doctor, and was told the wire was growing into her gums, her jaw bone was not growing back together like it should, and that she would have to go through more surgery to fix the problem.
But here's the kicker, we discovered the doctor who did the original surgery, had just opened her practice, and had never performed this type of surgery before, and of course did not know how to perform the surgery needed to correct the problem.
So my friend was referred to another doctor who could do the procedure. The problem however is that he was not listed with HMO. The doctor had to go through hoops trying to get HMO to cover the procedure.
They needed proof, documentation and pictures before they would even consider approving her surgery. It took them one month to approve the corrective surgery. In the end, it took a total of 4 months to get her jaw fixed, fifteen days from work, 25 pounds of lost weight, and more aggravation than you need to go through when you're sick.
The only thing I can fault her for is not checking out the doctor, the way we all should. Being listed with HMO doesn't mean anything, and it surely doesn't mean the doctor knows what they are doing.
So I've listed a few of the problems you could possibly run into with HMO, and how you can avoid them.
Check The List Of Doctors With Your HMO:
Choosing Your HMO Doctor:
Be very polite and ask them about their medical training, and if they have ever done the type of surgery you are scheduled for. If they won't or don't answer you questions, then you should find another doctor.
HMOs may be a little reluctant in letting you change doctors, but if you insist, they will eventually agree. It is better to go through this, than using a doctor who you either don't like or can't perform the procedure you need.
Getting A Second Opinion:
If they both belong to your HMO, the second doctor may be rather hesitant to give an honest opinion, because he's afraid of offending his friend or colleague.
What you may need to do is go outside your HMO plan, and find a doctor that has no relationship with your doctor, and has nothing to gain.
You need to check with your HMO to see if they would cover a second opinion from outside the plan. If they don't, you might want to consider doing it on your own, but the money would come out of your pockets.Continue reading.
Roe v. Wade
Stem Cell Fight!
Bush the hypocrite
June 2005 July 2005 August 2005 September 2005 October 2005 December 2005 March 2006 April 2006 May 2006 July 2006 August 2006 September 2006 October 2006 November 2006 January 2007 February 2007 March 2007 April 2007 May 2007 June 2007 July 2007 August 2007 September 2007 October 2007 November 2007 December 2007 January 2008 February 2008 March 2008 March 2009 November 2009 April 2010 October 2010 April 2011 May 2011 January 2012 February 2012 March 2012 April 2012 May 2012 June 2012 November 2012 December 2012 January 2013 February 2013 March 2013 April 2013 May 2013